India Pharma Outlook Team | Friday, 21 November 2025
Royal Philips, a worldwide frontrunner in health technology, revealed a prolonged collaboration with Cortechs.ai, an innovator in quantitative neuroimaging solutions. The companies will collaborate to incorporate Cortechs.ai’s cutting-edge AI-driven neuroimaging analytics directly into Philips’ MR systems, equipping clinicians with quicker, more objective, and consistent insights regarding brain health. The partnership enhances Philips' role in precision neuro diagnostics by merging Philips’ advanced MR technologies with Cortechs.ai’s AI-powered quantitative neuro imaging software, revolutionizing the detection, monitoring, and management of neurological disorders."By enhancing our collaboration with Cortechs.ai, we are speeding up the shift to entirely quantitative, AI-driven neuroimaging,” stated Ioannis Panagiotelis, PhD, MRI business leader at Philips. “This integration enhances accuracy, consistency, and productivity in neurological MR, enabling clinicians to make quicker, more assured choices for patients with intricate brain disorders.”Philips is enhancing productivity and advancing care with thorough AI integration that addresses significant challenges in healthcare – including workforce shortages and the rising need for advanced diagnostics. AI assists radiologists in saving time, enhancing consistency, and increasing throughput by automatically producing quantitative reports within current workflows.
Objective numerical biomarkers improve diagnostic precision, facilitating more reliable evaluations and assured comparisons over time and between locations. By reducing manual post-processing via automated, quality-controlled workflows, technologists can concentrate more on what is most important – providing an improved, more personalized patient experience
“Cortechs.ai’s mission has always been to empower clinicians with actionable, quantitative insights,” said Kyle Frye, chief executive officer, Cortechs.ai. “By combining our advanced neuro analytics with Philips’ leading MR platform and AI infrastructure, we’re making it easier to personalize brain care and track neurological changes with precision.”